Gesynta Pharma AB
PrivateLast Round
Series B
Jul 22, 2025
Total Funding Raised
$35.6M
Momentum Score
50 /100
Company Overview
Gesynta Pharma AB is a pharmaceutical company that develops novel anti-inflammatory, pain-relieving pharmaceuticals for the treatment of chronic inflammatory diseases such as endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gesynta Pharma AB Comps
Public and private peers based on sector, stage, and business model.
Gesynta Pharma AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 22, 2025 | ||||
| Series B | Jan 20, 2025 | ||||
| VC Round | Jul 7, 2020 | ||||
| VC Round | Apr 4, 2019 | ||||
| Series A | Feb 26, 2018 |
Gesynta Pharma AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foreground Capital | Series B |
| Catalyze Capital | Series B |
| XGEN Venture | Series B |
| Innovestor Life Science | Series B |
| HealthCap | Series B |
| Industrifonden | Series B, VC Round |
| Innovestor Life Science Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
Phase 2 trial started for endometriosis drug vipoglanstat.
- Jul 22, 2025
$4M Series B round raised.
Gesynta Pharma AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gesynta Pharma AB's valuation, stock price, and market status.
